Navigation Links
National Pharmaceutical Council Board of Directors Elects Pfizer's Marie-Caroline Sainpy as Chairman
Date:10/27/2009

WASHINGTON, Oct. 27 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council's Board of Directors today announced that it has elected Marie-Caroline Sainpy, Regional President for the NE Primary Care Business Unit at Pfizer Inc, to serve as Chairman for 2009-2010.

Ms. Sainpy has served in a variety of senior roles at Pfizer, which she joined in 1982. Prior to her current position, she was Senior Vice President/General Manager of the Customer Business Unit and Commercial Operations for the U.S. Prior to joining Pfizer Ms. Sainpy worked for Organon's U.S. Pharmaceutical Division, and Lazard Freres in New York. She has served on NPC's Board since 2007, most recently as Vice Chairman.

"NPC welcomes Ms. Sainpy as chairman," said NPC President Dan Leonard. "She shares our commitment to high standards of research and encouraging pharmaceutical innovation to improve patients' lives."

She takes on the chairmanship at a critical time, with Congress debating health care reform and increasing funding in the area of comparative effectiveness research, and with employers becoming more engaged in insurance design and improving employee health and productivity. As a result, during the last year NPC has taken a more active role in participating with health care stakeholders to demonstrate and communicate the value of biopharmaceuticals and vaccines through practical, evidence-based tools.

"As health reform drives the government into a greater role in determining guidelines and reimbursement of patient care, NPC will play an increasingly important part in providing analysis to help ensure that patient access and clinical quality are important factors in policy determinations," said Ms. Sainpy.

The NPC Board also elected Kevin T. Rigby, Vice President of Public Affairs and Communications at Novartis Pharmaceuticals, to serve as its Vice Chairman, and Robert A. McMahon, President of U.S. Commercial Operations at Merck & Co., as Treasurer.

About the National Pharmaceutical Council

NPC's overarching mission is to sponsor and conduct scientific analyses of the appropriate use of biopharmaceuticals and the clinical and economic value of innovation. The organization's strategic focus is on evidence-based medicine (EBM) for health care decision-making, to ensure that patients have access to high-quality care. NPC was established in 1953 and is supported by the nation's major research-based pharmaceutical companies. For more information, visit www.npcnow.org.

SOURCE National Pharmaceutical Council


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Australia Ophthalmic Lasers Market Outlook to ... Lasers Market Outlook to 2022", provides key market data ... value, in millions of US dollars, volume (in units) ... Lasers, Femtosecond Lasers and YAG Lasers. The report ... each of these market segements, and global corporate-level profiles ...
(Date:12/8/2016)... Global Interventional Radiology Market: Scope and ... radiology market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/8/2016)... -- Allergy Diagnostics Market: Scope and Methodology ... used to determine the presence of allergens such ... in the samples by determining the presence of ... on global allergy diagnostics market, analyzes the current ... consists of an executive summary that provides information ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick Taché ... Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a ... & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... , ... December 08, 2016 , ... STAT courier is ... be a convenient service for Texas, they are expanding their presence in Dallas. One ... hiring spree that will bring new jobs to the Dallas and Forth Worth market. ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
Breaking Medicine News(10 mins):